Basal sFAS/sFASL ratio and FAS polymorphisms, as a prognostic marker, in advanced colorectal carcinoma patients (ACRC), treated with oxaliplatin-based chemotherapy.

被引：0
|
作者：
Gascon, P
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：278S / 278S
页数：1
相关论文
共 50 条
  • [41] Baseline neutrophil to lymphocyte ratio as a prognostic marker for patients with muscle-invasive bladder cancer being treated with neoadjuvant chemotherapy.
    Kaiser, Jeenan
    Li, Haocheng
    Seah, Jo-An
    Leibowitz-Amit, Raya
    North, Scott A.
    Sridhar, Srikala S.
    Heng, Daniel Yick Chin
    Alimohamed, Nimira S.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [42] Polymorphism of nucleotide excision repair genes as predictors for clinical outcome in advanced gastric cancer patients treated with oxaliplatin-based chemotherapy
    Hur, H.
    Song, K.
    Park, C.
    Hong, Y.
    Chun, H.
    Jeon, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [43] Simplified Prognostic Model in Patients with Oxaliplatin-Based or Irinotecan-Based First-Line Chemotherapy for Metastatic Colorectal Cancer: A GERCOR Study
    Chibaudel, Benoist
    Bonnetain, Franck
    Tournigand, Christophe
    Bengrine-Lefevre, Leila
    Teixeira, Luis
    Artru, Pascal
    Desrame, Jerome
    Larsen, Annette K.
    Andre, Thierry
    Louvet, Christophe
    de Gramont, Aimery
    ONCOLOGIST, 2011, 16 (09): : 1228 - 1238
  • [44] Post-chemotherapeutic CEA and CA19-9 Are Prognostic Factors in Patients with Colorectal Liver Metastases Treated with Hepatic Resection After Oxaliplatin-based Chemotherapy
    Sakamoto, Yasuo
    Miyamoto, Yuji
    Beppu, Toru
    Nitta, Hidetoshi
    Imai, Katsunori
    Hayashi, Hiromitsu
    Baba, Yoshifumi
    Yoshida, Naoya
    Chikamoto, Akira
    Baba, Hideo
    ANTICANCER RESEARCH, 2015, 35 (04) : 2359 - 2368
  • [45] Lack of association with epidermal growth factor receptor gene polymorphisms with clinical outcome in patients with advanced colorectal cancer treated with platinum-based chemotherapy.
    Park, D. J.
    Zhang, W.
    Gordon, M.
    Yang, D. Y.
    Ladner, R.
    Iqbal, S.
    Groshen, S.
    Vallbohmer, D.
    Lenz, H.
    Fazzone, W.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 140S - 140S
  • [46] CEA and CA19.9 as Early Predictors of Progression in Advanced/Metastatic Colorectal Cancer Patients Receiving Oxaliplatin-Based Chemotherapy and Bevacizumab
    Petrioli, Roberto
    Licchetta, Antonella
    Roviello, Giandomenico
    Pascucci, Alessandra
    Francini, Edoardo
    Bargagli, Gianluca
    Conca, Raffaele
    Miano, Salvatora Tindara
    Marzocca, Giuseppe
    Francini, Guido
    CANCER INVESTIGATION, 2012, 30 (01) : 65 - 71
  • [47] MGMT-535G> T POLYMORPHISM IS ASSOCIATED WITH PROGNOSIS FOR PATIENTS WITH METASTATIC COLORECTAL CANCER TREATED WITH OXALIPLATIN-BASED CHEMOTHERAPY
    Kang, B. W.
    Kim, J. G.
    Chae, Y. S.
    Lee, S. J.
    Do, Y. R.
    Lee, W. S.
    ANNALS OF ONCOLOGY, 2010, 21 : 209 - 210
  • [48] Association of High LAT1 Expression with Poor Prognosis and Recurrence in Colorectal Cancer Patients Treated with Oxaliplatin-Based Adjuvant Chemotherapy
    Shibasaki, Yuta
    Yokobori, Takehiko
    Sohda, Makoto
    Shioi, Ikuma
    Ozawa, Naoya
    Komine, Chika
    Suga, Kunihiko
    Nakazawa, Nobuhiro
    Osone, Katsuya
    Shiraishi, Takuya
    Okada, Takuhisa
    Sano, Akihiko
    Sakai, Makoto
    Ogawa, Hiroomi
    Kaira, Kyoichi
    Shirabe, Ken
    Saeki, Hiroshi
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (03)
  • [49] Promoter Methylation of RASSF1A indicates Prognosis for Patients with Stage II and III Colorectal Cancer Treated with Oxaliplatin-Based Chemotherapy
    Sun, Xicai
    Yuan, Wei
    Hao, Furong
    Zhuang, Wenzhen
    MEDICAL SCIENCE MONITOR, 2017, 23 : 5389 - 5395
  • [50] MGMT-535G>T POLYMORPHISM IS ASSOCIATED WITH PROGNOSIS FOR PATIENTS WITH METASTATIC COLORECTAL CANCER TREATED WITH OXALIPLATIN-BASED CHEMOTHERAPY
    Kim, J. G. K.
    Choi, G. S. C.
    Chung, H. Y. C.
    Jun, S. H. J.
    Lim, K. H. L.
    Kang, B. W. K.
    Jeon, S. W. J.
    ANNALS OF ONCOLOGY, 2010, 21 : I35 - I35
12345